Drug Shortage Report for TEVA-PERINDOPRIL/INDAPAMIDE
Report ID | 240069 |
Drug Identification Number | 02464039 |
Brand name | TEVA-PERINDOPRIL/INDAPAMIDE |
Common or Proper name | PERIN/INDA 8MG/2.5MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | INDAPAMIDE PERINDOPRIL ERBUMINE |
Strength(s) | 2.5MG 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2025-01-29 |
Estimated end date | 2025-02-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-02-03 | French | Compare |
v3 | 2025-02-03 | English | Compare |
v2 | 2024-10-11 | French | Compare |
v1 | 2024-10-11 | English | Compare |
Showing 1 to 4 of 4